Effect of a Decision Aid on Knowledge and Treatment Decision Making for Breast Cancer Surgery
JAMAPublished 27 July 2004
Timothy J. Whelan, Mark N. Levine, Andrew R. Willan, Amiram Gafni, Ken Sanders, Doug Mirsky
Citations410
SJR quartileQ1
SJR score5.35
SNIP10.71
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The decision board was helpful in improving communication and enabling women to make a choice regarding treatment, and should be considered by surgeons when communicating the different surgical options to women with breast cancer.
Abstract
The decision board was helpful in improving communication and enabling women to make a choice regarding treatment. Such instruments should be considered by surgeons when communicating the different surgical options to women with breast cancer.
Keywords
MedicineHealth ProfessionsBiochemistry, Genetics and Molecular Biology
Controlled Clinical TrialsMeta-analysis in clinical trials
39,316 Citations1986Rebecca DerSimonian, Nan M. Laird
This paper examines eight published reviews each reporting results from several related trials in order to evaluate the efficacy of a certain treatment for a specified medical condition and suggests a simple noniterative procedure for characterizing the distribution of treatment effects in a series of studies.
New England Journal of MedicineTwenty-Year Follow-up of a Randomized Study Comparing Breast-Conserving Surgery with Radical Mastectomy for Early Breast Cancer
4,388 Citations2002Umberto Veronesi, Natale Cascinelli +6 more
The long-term survival rate among women who undergo breast-conserving surgery is the same as that among women Who undergo radical mastectomy, and Breast-conserve surgery is therefore the treatment of choice for women with relatively small breast cancers.
Medical Decision MakingValidation of a Decisional Conflict Scale
2,454 Citations1995Annette M. O’Connor
The psychometric properties of a decisional conflict scale (DCS) that elicits health-care consumers' uncertainty in making a health-related decision and the factors contributing to the uncertainty are acceptable.
New England Journal of MedicineFive-Year Results of a Randomized Clinical Trial Comparing Total Mastectomy and Segmental Mastectomy with or without Radiation in the Treatment of Breast Cancer
2,204 Citations1985Bernard Fisher, Madeline Bauer +17 more
It is concluded that segmental mastectomy, followed by breast irradiation in all patients and adjuvant chemotherapy in women with positive nodes, is appropriate therapy for Stage I and II breast tumors less than or equal to 4 cm, provided that margins of resected specimens are free of tumor.
New England Journal of MedicineComparing Radical Mastectomy with Quadrantectomy, Axillary Dissection, and Radiotherapy in Patients with Small Cancers of the Breast
1,611 Citations1981Umberto Veronesi, Roberto Saccozzi +13 more
From these results, mastectomy appears to involve unnecessary mutilation in patients with breast cancer of less than 2 cm and no palpable axillary lymph nodes.
Design and Analysis of Group-Randomized Trials
1,124 Citations2007David M. Murray
This paper focuses on the design and analysis of nested cross-Sectional designs and the applications of these designs in the context of nested Cohort designs.
BMJPsychological outcomes of different treatment policies in women with early breast cancer outside a clinical trial.
751 Citations1990Lesley Fallowfield, Angela Hall +2 more
There is still no evidence that women with early breast cancer who undergo breast conservation surgery have less psychiatric morbidity after treatment than those who undergo mastectomy, and patients treated by surgeons who offered a choice showing less depression than those treated by other surgeons.
PubMedRandomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial.
446 Citations1992van Dongen Ja, Harry Bartelink +8 more
Tumor size was found in univariate analysis to be a significant risk factor for local recurrence in the breast-conserving therapy group but not in the mastectomy group, and Measurements of quality of life and cosmesis show a clear benefit for the Breast-conserve therapy group.
Journal of Clinical OncologyThe practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation.
445 Citations1995George P. Browman, Mark N. Levine +5 more
Attention to the barriers of guidelines development and the sociocultural nature of clinical practice, and respect for clinical experience, can lead to improved strategies for guidelines development.
Psychology and HealthMeasuring depressive symptoms in illness populations: Psychometric properties of the Center for Epidemiologic Studies Depression (CES-D) Scale
416 Citations1988Gerald M. Devins, Carolee M. Orme +5 more
The CES-D's factorial composition was highly similar to that observed among community volunteers and this pattern did not change despite differences in physical health and illness.
European Journal of CancerQuality of life of early-stage breast cancer patients treated with radical mastectomy or breast-conserving procedures: results of EORTC trial 10801
353 Citations1998Desmond Curran, J P van Dongen +5 more
In this multicentre randomised study, BCT helped to maintain the patients' body image, resulted in higher satisfaction with treatment and yielded no significant difference from MRM with respect to fear of recurrence.
Journal of Clinical OncologyMastectomy versus breast-conserving therapy in the treatment of stage I and II carcinoma of the breast: a randomized trial at the National Cancer Institute.
347 Citations1992Allen S. Lichter, Marc E. Lippman +8 more
Data from this study add further weight to the conclusion that breast conservation using lumpectomy and breast irradiation is equivalent to mastectomy in terms of survival and ultimate local control for stage I and II breast cancer patients.
CancerIncreasing patient involvement in choosing treatment for early breast cancer
296 Citations1995Richard L. Street, Becky Voigt +3 more
This investigation examined factors affecting patient involvement in consultations to decide local treatment for early breast cancer and the effectiveness of two methods of preconsultation education aimed at increasing patient participation in these discussions.
Annals of Internal MedicineA Bedside Decision Instrument To Elicit a Patient's Preference Concerning Adjuvant Chemotherapy for Breast Cancer
281 Citations1992Mark N. Levine, Amiram Gafni +2 more
The instrument has been used to elicit treatment preferences in 37 newly presenting patients with high-risk, node-negative breast cancer and has been found to be acceptable and helpful to the patient.
The Lancet OncologyInforming and involving cancer patients in their own care
260 Citations2002Michael Jefford, Martin H.N. Tattersall
The information needs and participation preferences of patients with cancer and the consequences of not meeting these expectations are discussed and the types of information resources developed focusing on their reported effectiveness are reviewed.
Health PsychologyPsychosocial outcomes of breast-conserving surgery versus mastectomy: A meta-analytic review.
239 Citations1997Anne Moyer
Meta-analytic methods were used to summarize the findings of 40 investigations and Modest advantages for breast-conserving surgery were identified for psychological, marital-sexual, and social adjustment; body/self-image; and cancer-related fears and concerns.
JNCI Journal of the National Cancer InstituteHelping Patients Make Informed Choices: A Randomized Trial of a Decision Aid for Adjuvant Chemotherapy in Lymph Node-Negative Breast Cancer
225 Citations2003Timothy J. Whelan, Carol Sawka +11 more
When making decisions regarding adjuvant chemotherapy, patients with early breast cancer who had been exposed to the Decision Board had better knowledge of the disease and treatment options and greater satisfaction with their decision making than those who received the standard consultation.
Medical Decision MakingRandomized Trial of a Patient Decision Aid for Choice of Surgical Treatment for Breast Cancer
183 Citations2001Vivek Goel, Carol Sawka +3 more
Although the decision aid had minimal impact on the main study outcomes, a subgroup of women who were initially leaning toward mastectomy or were unsure had lower decisional conflict and may have benefited.
Journal of Clinical OncologyDecision Support for Patients With Early-Stage Breast Cancer: Effects of an Interactive Breast Cancer CDROM on Treatment Decision, Satisfaction, and Quality of Life
172 Citations2001Sjaak Molenaar, Mirjam A. G. Sprangers +7 more
The Interactive Breast Cancer CDROM improved decision making in patients with early-stage breast cancer with a choice between BCT and MT, as evaluated in terms of patients' satisfaction and QoL.
Journal of Clinical OncologyCommunication Between Physicians and Older Women With Localized Breast Cancer: Implications for Treatment and Patient Satisfaction
167 Citations2002Wenchi Liang
Greater patient-physician communication was associated with a sense of choice, actual treatment, and satisfaction with care, and the quality of cancer care for older breast cancer patients may be improved through interventions that improve communication within the physician-patient dyad.
PubMedBreast-conserving therapy vs mastectomy in early-stage breast cancer: a meta-analysis of 10-year survival.
161 Citations1997Astrid Morris, Robert D. Morris +8 more
Patients allocated to BCT have survival rates at least as high as patients allocated to mastectomy, and BCT may confer a relative survival advantage over mastectomy under some conditions, particularly for node-positive patients.
Journal of Clinical OncologyMastectomy or Lumpectomy? Helping Women Make Informed Choices
132 Citations1999Timothy J. Whelan, Mark N. Levine +9 more
The Decision Board is a simple method to improve communication and facilitate shared decision making and was well accepted by patients and surgeons and easily applied in the community.
BMJCommunicate with cancer patients: 1. Handling bad news and difficult questions.
121 Citations1988Peter Maguire, Alison Faulkner
Advice is provided to doctors and nurses on how to go about telling patients that they have cancer and how to respond to patients' questions and concerns about their prognosis and treatment.
Journal of Health Services Research & PolicyDecision aids: are they worth it? A systematic review
105 Citations2001Carole A. Estabrooks, Vivek Goel +4 more
Improved outcomes result from the use of CDA in some categories of outcome but insufficient evidence exists yet to support improved outcomes in all categories or to evaluate whether, given the considerable costs of many CDAs, funding for extensive ongoing development and testing can be sustained.
Gynecologic OncologyPatients’ Preferences for Therapy in Advanced Epithelial Ovarian Cancer: Development, Testing, and Application of a Bedside Decision Instrument
94 Citations1996Laurie Elit, Mark N. Levine +5 more
The Decision Board is a reliable and valid method for sharing information about advanced ovarian cancer with patients and it was feasible to provide survival information to 98% of the healthy women.
Journal of Clinical OncologyUse of breast-conserving surgery for treatment of stage I and stage II breast cancer.
93 Citations1998Edward Guadagnoli, Jane C. Weeks +4 more
The rate of breast-conserving surgery in each state was higher than expected based on earlier reports, but the rates differed considerably between states.
Patient Education and CounselingA qualitative study of physicians’ perceptions of three decision aids
79 Citations2003Ian D. Graham, Jo Logan +11 more
Uptake of decision aids may be facilitated if physicians have an opportunity to examine and try them, and if they can have unfettered access to them for distribution purposes.
JNCI Journal of the National Cancer InstituteStandard Consultations Are Not Enough to Ensure Decision Quality Regarding Preference-Sensitive Options
48 Citations2003Annette M. O’Connor, Albert G. Mulley +1 more
The first randomized controlled trial of a decision board for women considering chemotherapy for lymph node-negative breast cancer is reported, confirming the efficacy of their particular approach in achieving improvement in decision quality and adding to the mounting evidence of the effectiveness of decision aids.
Journal of Clinical OncologyProposed Agenda for the Measurement of Quality-of-Care Outcomes in Oncology Practice
48 Citations1999Jeanne S. Mandelblatt, Patricia A. Ganz +1 more
CancerResults of the Lynn Sage Second‐Opinion Program for local therapy in patients with breast carcinoma
43 Citations2002Jennifer Clauson, Y. C. Hsieh +3 more
How often a second opinion on the local therapy of breast carcinoma changed patient management is determined and factors predictive of remaining at the second‐opinion site for therapy are identified.
PubMedImpact of cancer-related decision aids.
37 Citations2002Timothy J. Whelan, Mary Ann O’Brien +8 more
The objective of this study was to conduct a comprehensive, systematic review of the literature to determine the impact of decision aids on cancer prevention, screening, and treatment decisions.
Health ExpectationsLessons learned from the Decision Board: a unique and evolving decision aid
35 Citations2000Timothy J. Whelan, Amiram Gafni +2 more
The experience and lessons learned through the development and use of the Decision Board are reported, a uniquely interactive decision aid administered by the clinician during the medical consultation.